Sunday, April 12, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Banking & Insurance

Fiserv Rolls Out 24/7 USD Settlement Tool to Challenge Stablecoins

SiterGedge by SiterGedge
February 13, 2026
in Banking & Insurance, Blockchain, Crypto Stocks, Tech & Software
0
Fiserv Stock
0
SHARES
10
VIEWS
Share on FacebookShare on Twitter

Fiserv has unveiled a new platform, INDX, aimed at letting institutional crypto players settle US dollars around the clock while sidestepping the regulatory risks tied to digital tokens. Debuted on February 12, the solution targets a core mismatch: blockchain settlements operate continuously, whereas traditional banking functions within standard business hours. INDX is designed to fill that gap.

Key specifications
– Real-time USD settlement, 365 days a year
– FDIC insurance up to $25 million per account (twenty times the standard limit)
– Connectivity to more than 1,100 US banking institutions via the Fiserv Deposit Network

Off-chain, but blockchain-fast
The centerpiece is that funds stay off-chain within a regulated banking system yet move with the speed typical of blockchain settlements. By doing so, INDX presents itself as a compliant alternative to popular stablecoins such as USDC or Tether, eliminating smart-contract exposure and concerns around collateralization.

The platform also aligns with CEO Mike Lyons’ “One Fiserv” initiative, which seeks to knit the company’s fragmented technologies together to unlock synergies across the organization.

Should investors sell immediately? Or is it worth buying Fiserv?

Recent earnings context
The INDX unveiling followed the company’s Q4 earnings release on February 10, which offered several positives after a challenging year. Highlights include:

  • Adjusted Q4 EPS: $1.99 (consensus $1.90–$1.92)
  • Q4 revenue: about $4.90 billion (essentially flat versus the prior year)
  • 2026 guidance: EPS $8.00–$8.30, organic revenue growth of 1–3%

The stock moved higher briefly after the results, with investors rewarding the improved profitability even as the revenue outlook remained cautious.

Analyst sentiment
On February 11, Stephens trimmed its target price to $70, signaling persistent caution. JPMorgan and other houses have also adjusted targets in recent days. The prevailing view among analysts is that valuations look modest relative to the growth outlook, and that organic growth remains a challenge.

What to watch next
The big questions now are whether INDX can generate meaningful volumes and whether the second-half 2026 execution of the One Fiserv reorganization will deliver genuine growth momentum. Market adoption of the new settlement framework for digital assets could serve as a catalyst, assuming institutional clients pivot away from stablecoins toward this regulated, faster, off-chain solution.

Ad

Fiserv Stock: Buy or Sell?! New Fiserv Analysis from April 11 delivers the answer:

The latest Fiserv figures speak for themselves: Urgent action needed for Fiserv investors. Is it worth buying or should you sell? Find out what to do now in the current free analysis from April 11.

Fiserv: Buy or sell? Read more here...

Tags: Fiserv
SiterGedge

SiterGedge

Related Posts

Strategy Stock
Analysis

Strategy’s Solitary Bitcoin Bet: A $14.5 Billion Paper Loss and Unwavering Conviction

April 11, 2026
MSCI World ETF Stock
ETF

iShares MSCI World ETF: Stability Anchored by a Handful of Tech Titans

April 10, 2026
Coinbase Stock
Analysis

Coinbase Faces a Volatility Trap as Trading Slumps and New Products Launch

April 10, 2026
Next Post
Coinbase Stock

Coinbase Slips into Loss After Eight Quarters of Profit

Apex Critical Metals Stock

Apex Critical Metals accelerates Rift drilling with a second rig in Nebraska

Cyclacel Pharmaceuticals Stock

From Biotech to Fire-Protection: Bio Green Med’s Strategic Pivot

Recommended

Infineon Stock

Infineon’s Strategic Pivot Amid Rising Asian Competition in Power Semiconductors

4 weeks ago
Asbury Automotive Stock

Asbury Automotive’s Expansion Strategy Faces Market Skepticism

8 months ago
ePlus Stock

ePlus Stock: A Quiet Transformation Gains Momentum

7 months ago
Rimini Stock

Rimini Street Stock: Executive Sales Cloud Strong Growth Narrative

7 months ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Bloom Energy Broadcom Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Oracle Palantir PayPal Plug Power Realty Income Robinhood Rocket Lab USA Salesforce Strategy Synopsys Take-Two Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Shadow Banks, Record Defaults, and the $1.8 Trillion Fracture

Orora’s Strategic Pivot: Shifting Glass Production from the Middle East to Mexico

Fermi’s Texas Power Gamble Faces Investor Exodus and Delays

iShares MSCI World ETF: Stability Anchored by a Handful of Tech Titans

Coinbase Faces a Volatility Trap as Trading Slumps and New Products Launch

Ams Osram’s Gold Problem Meets AI Optimism

Trending

ImmunityBio Stock
Analysis

ImmunityBio’s Record Revenue Meets Mounting Legal Pressure

by Jackson Burston
April 11, 2026
0

ImmunityBio's stock is navigating a volatile path, caught between explosive commercial growth for its bladder cancer drug...

Strategy Stock

Strategy’s Solitary Bitcoin Bet: A $14.5 Billion Paper Loss and Unwavering Conviction

April 11, 2026
BioNTech Stock

BioNTech’s Oncology Drive Gains Momentum with Key Data and Analyst Backing

April 11, 2026
Shadow Banks, Record Defaults, and the $1.8 Trillion Fracture

Shadow Banks, Record Defaults, and the $1.8 Trillion Fracture

April 11, 2026
Orora Stock

Orora’s Strategic Pivot: Shifting Glass Production from the Middle East to Mexico

April 10, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • ImmunityBio’s Record Revenue Meets Mounting Legal Pressure
  • Strategy’s Solitary Bitcoin Bet: A $14.5 Billion Paper Loss and Unwavering Conviction
  • BioNTech’s Oncology Drive Gains Momentum with Key Data and Analyst Backing

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com